GSK plc (GLAXF)
OTCMKTS · Delayed Price · Currency is USD
27.23
0.00 (0.00%)
Mar 9, 2026, 9:30 AM EST

GSK plc Income Statement

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
---29,32424,696
Revenue Growth (YoY)
---18.74%1.40%
Cost of Revenue
9,0179,0488,5659,5548,163
Gross Profit
23,65022,32821,76319,77016,533
Selling, General & Admin
9,08811,0159,3858,3727,070
Research & Development
7,5256,4016,2235,4885,019
Other Operating Expenses
-895891-590-52387
Operating Income
7,9324,0216,7456,4334,357
Interest Income
1691221157614
Interest Expense
-701-669-792-879-769
Other Non-Operating Income (Expense)
13-4-233
Total Non-Operating Income (Expense)
-531-544-681-805-722
Pretax Income
7,4013,4776,0645,6283,599
Provision for Income Taxes
1,11252675670783
Net Income
5,7162,5754,92814,9564,385
Minority Interest in Earnings
573376380665711
Earnings From Discontinued Operations
---21,4003,160
Net Income to Common
5,7162,5754,92814,9564,385
Net Income Growth
121.98%-47.75%-67.05%241.07%-23.73%
Shares Outstanding (Basic)
2,0262,0392,0262,0132,002
Shares Outstanding (Diluted)
2,0592,0712,0562,0422,026
Shares Change (YoY)
-0.60%0.75%0.66%0.79%0.55%
EPS (Basic)
2.821.262.437.431.66
EPS (Diluted)
2.781.242.407.321.64
EPS Growth
123.15%-48.12%-67.26%347.68%-42.64%
Free Cash Flow
15,33613,01613,550-374725
Free Cash Flow Growth
17.82%-3.94%---16.09%
Free Cash Flow Per Share
7.456.286.59-0.180.36
Dividends Per Share
0.6600.6100.5800.6131.000
Dividend Growth
8.20%5.17%-5.31%-38.75%-
Gross Margin
---67.42%66.95%
Operating Margin
---21.94%17.64%
Profit Margin
---123.32%34.87%
FCF Margin
----1.28%2.94%
EBITDA
10,2466,5729,0396,4334,357
EBITDA Margin
---21.94%17.64%
EBIT
7,9324,0216,7456,4334,357
EBIT Margin
---21.94%17.64%
Effective Tax Rate
15.02%15.13%12.47%12.56%2.31%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.